相似文献
1
Urotensin II evokes potent vasoconstriction in humans in vivo.
Br J Pharmacol. 2002 Jan;135(1):25-7. doi: 10.1038/sj.bjp.0704448.
2
Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
Clin Pharmacol Ther. 2000 Jul;68(1):67-74. doi: 10.1067/mcp.2000.107523.
3
High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man.
Cardiovasc Res. 2002 Feb 1;53(2):341-7. doi: 10.1016/s0008-6363(01)00485-0.
4
Effect of the non peptide angiotensin II antagonist, GR117289C on the vasoconstrictor actions of angiotensin II in the human forearm.
Br J Clin Pharmacol. 1997 Mar;43(3):323-6.
5
Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
J Cardiovasc Pharmacol. 1988;11 Suppl 1:S41-3.
6
Heterogeneous vascular response to vasopressin: radial artery versus forearm blood flow.
J Hypertens. 1997 Jan;15(1):35-41.
7
Selective AT1 receptor antagonism enhances sympathetically mediated vasoconstriction in man.
Clin Pharmacol Ther. 2007 Jan;81(1):83-7. doi: 10.1038/sj.clpt.6100023.
8
Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
Clin Pharmacol Ther. 2006 Mar;79(3):263-73. doi: 10.1016/j.clpt.2005.11.005. Epub 2006 Feb 7.
9
In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Circulation. 2006 Aug 1;114(5):414-21. doi: 10.1161/CIRCULATIONAHA.105.590232. Epub 2006 Jul 24.
10
Local arterial vasoconstriction induced by octreotide in patients with cirrhosis.
Hepatology. 2000 Mar;31(3):572-6. doi: 10.1002/hep.510310304.
引用本文的文献
1
The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.
Front Endocrinol (Lausanne). 2017 Apr 25;8:76. doi: 10.3389/fendo.2017.00076. eCollection 2017.
2
The role of neuropeptides in adverse myocardial remodeling and heart failure.
Cell Mol Life Sci. 2017 Jun;74(11):2019-2038. doi: 10.1007/s00018-017-2452-x. Epub 2017 Jan 17.
3
Association between human urotensin II and essential hypertension--a 1:1 matched case-control study.
PLoS One. 2013 Dec 10;8(12):e81764. doi: 10.1371/journal.pone.0081764. eCollection 2013.
4
Urotensin-II: More Than a Mediator for Kidney.
Int J Nephrol. 2012;2012:249790. doi: 10.1155/2012/249790. Epub 2012 Oct 10.
5
Endogenous urotensin II selectively modulates erectile function through eNOS.
PLoS One. 2012;7(2):e31019. doi: 10.1371/journal.pone.0031019. Epub 2012 Feb 2.
6
Potential Clinical Implications of the Urotensin II Receptor Antagonists.
Front Pharmacol. 2011 Jul 22;2:38. doi: 10.3389/fphar.2011.00038. eCollection 2011.
7
Renal impairment, hypertension and plasma urotensin II.
Nephrol Dial Transplant. 2011 Feb;26(2):609-14. doi: 10.1093/ndt/gfq416. Epub 2010 Jul 9.
8
The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans.
Br J Clin Pharmacol. 2009 Oct;68(4):518-23. doi: 10.1111/j.1365-2125.2009.03475.x.
9
Endothelial progenitor cells & translational research.
Br J Clin Pharmacol. 2009 Oct;68(4):477-9. doi: 10.1111/j.1365-2125.2009.03538.x.
10
Urotensin II in cardiovascular regulation.
Vasc Health Risk Manag. 2008;4(4):775-85. doi: 10.2147/vhrm.s1983.
本文引用的文献
1
Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats.
Br J Pharmacol. 2001 Apr;132(8):1625-9. doi: 10.1038/sj.bjp.0704051.
2
Effects of urotensin II in human arteries and veins of varying caliber.
Circulation. 2001 Mar 13;103(10):1378-81. doi: 10.1161/01.cir.103.10.1378.
3
Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries.
Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H925-8. doi: 10.1152/ajpheart.2001.280.2.H925.
4
Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1.
Br J Pharmacol. 2000 Oct;131(3):441-6. doi: 10.1038/sj.bjp.0703601.
5
Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries.
Br J Pharmacol. 2000 Aug;130(8):1865-70. doi: 10.1038/sj.bjp.0703513.
6
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
Nature. 1999 Sep 16;401(6750):282-6. doi: 10.1038/45809.
7
Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15803-8. doi: 10.1073/pnas.95.26.15803.
8
Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.
Proc Natl Acad Sci U S A. 1980 Aug;77(8):5021-4. doi: 10.1073/pnas.77.8.5021.
9
Potent vasoconstrictor effects and clearance of endothelin in the human forearm.
Acta Physiol Scand. 1991 Mar;141(3):319-24. doi: 10.1111/j.1748-1716.1991.tb09087.x.
Zotero 插件